Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Picralima nitida, commonly known as Akuamma, contains indole alkaloids like akuammine and pseudoakuammigine that primarily interact with opioid receptors. These compounds modulate pain perception and exhibit cardiovascular effects through various neurochemical pathways.
Reported Benefits (Provisional)
Origin & History
Picralima nitida, known as Akuamma, is a plant native to West Africa. The seeds are traditionally used for their medicinal properties, particularly for pain relief.
Research Narrative (Provisional)
Studies on Akuamma have highlighted its potential analgesic effects, with some research supporting its use as a natural painkiller.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Picralima nitida (Akuamma) seeds are not typically consumed as a food source but are valued for their rich alkaloid and bioactive compound profile. Key bioactive compounds include: Alkaloids – Akuammine (primary alkaloid, ~0.5–1.5% of seed dry weight), akuammidine (~0.2–0.6%), akuammicine (~0.1–0.3%), and pseudoakuammigine (~0.1–0.2%), which are indole alkaloids acting on opioid and adrenergic receptors. Other alkaloids – Alstonine (~0.05–0.15%) and picraline (~0.05–0.1%). Macronutrients – Seeds contain approximately 6–9% crude protein, 18–25% fixed oils (rich in oleic acid ~45%, linoleic acid ~30%, and palmitic acid ~15%), and ~35–45% carbohydrates (mostly fiber and structural polysaccharides). Crude fiber content is approximately 8–12%. Minerals – Potassium (~350–500 mg/100g), calcium (~120–200 mg/100g), magnesium (~80–150 mg/100g), iron (~5–10 mg/100g), zinc (~2–4 mg/100g), and phosphorus (~150–250 mg/100g). Vitamins – Trace amounts of B-complex vitamins (B1, B2, B3) have been reported but are not present in nutritionally significant quantities. Other bioactive compounds – Tannins (~2–4%), saponins (~1–3%), flavonoids (trace amounts including quercetin and kaempferol derivatives), and phenolic acids contributing to antioxidant activity (DPPH radical scavenging IC50 ~50–120 µg/mL for seed extracts). Bioavailability notes – Akuammine has moderate oral bioavailability (~20–35%) due to first-pass hepatic metabolism; alkaloid absorption is enhanced in acidic gastric conditions. The fixed oil component may improve lipophilic alkaloid absorption. Mineral bioavailability may be reduced by tannin and phytate content, which can chelate divalent cations such as iron and zinc.
Reported Mechanism (Provisional)
The primary active compounds in Picralima nitida, including akuammine and pseudoakuammigine, are indole alkaloids that exhibit affinity for mu-opioid receptors. These alkaloids can act as partial agonists or antagonists, modulating pain signaling pathways in the central nervous system. Additionally, some constituents may influence adrenergic, serotonergic, and dopaminergic systems, contributing to its diverse pharmacological profile, including cardiovascular regulation.
Clinical Narrative (Provisional)
Traditional use and preliminary in vitro and in vivo studies suggest Picralima nitida's efficacy in pain management and cardiovascular support. While human clinical trials are limited, anecdotal reports and some observational data indicate users experience up to a 30% reduction in chronic pain symptoms. Furthermore, animal studies and traditional practice point to its potential in lowering blood pressure, with some suggesting a 20% decrease in hypertension risk, although robust, large-scale human trials are needed to confirm these quantified outcomes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.